Supreme Court Blocks Restrictions on Abortion Pill Mifepristone

The ruling halts a decision by the 5th Circuit Court of Appeals that sought to reinstate strict requirements for in-person dispensing of the drug. Justices Samuel Alito and Clarence Thomas dissented from the decision, which maintains the FDA’s 2023 rule permitting broader access. The case stems from a challenge to the agency’s authority to permanently lift in-person mandates, a move that became a focal point for conservative legal strategy following the reversal of Roe v. Wade.

Advocates emphasize that the legal reprieve is not a permanent victory. Julia Kaye of the ACLU warned that opponents of reproductive care continue to pursue baseless attacks, while Nourbese Flint of All